ketoACE | CAS#74075-33-5 | amide bond

MedKoo Cat#: 597858 | Name: ketoACE

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ketoACE is an amide bond between Phe-Gly of tripeptide replaced with ketomethylene.

Chemical Structure

ketoACE

CAS#74075-33-5

Theoretical Analysis

MedKoo Cat#: 597858

Name: ketoACE

CAS#: 74075-33-5

Chemical Formula: C24H26N2O5

Exact Mass: 422.1842

Molecular Weight: 422.48

Elemental Analysis: C, 68.23; H, 6.20; N, 6.63; O, 18.93

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

ketoACE; Ketoace; Sri 20; Sri-20; Sri20;

IUPAC/Chemical Name

((S)-5-benzamido-4-oxo-6-phenylhexanoyl)-L-proline

InChi Key

WZJFKVHMXBGZBQ-PMACEKPBSA-N

InChi Code

InChI=1S/C24H26N2O5/c27-21(13-14-22(28)26-15-7-12-20(26)24(30)31)19(16-17-8-3-1-4-9-17)25-23(29)18-10-5-2-6-11-18/h1-6,8-11,19-20H,7,12-16H2,(H,25,29)(H,30,31)/t19-,20-/m0/s1

SMILES Code

O=C(O)[C@H]1N(C(CCC([C@@H](NC(C2=CC=CC=C2)=O)CC3=CC=CC=C3)=O)=O)CCC1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 422.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Morentin Gutierrez P, Gyte A, deSchoolmeester J, Ceuppens P, Swales J, Stacey C, Eriksson JW, Sjöstrand M, Nilsson C, Leighton B. Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice. Br J Pharmacol. 2015 Oct;172(20):4806-16. doi: 10.1111/bph.13251. Epub 2015 Oct 8. PubMed PMID: 26218540; PubMed Central PMCID: PMC4621984. 2: Ziff J, Rudolph DA, Stenne B, Koudriakova T, Lord B, Bonaventure P, Lovenberg TW, Carruthers NI, Bhattacharya A, Letavic MA, Shireman BT. Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists. ACS Chem Neurosci. 2016 Apr 20;7(4):498-504. doi: 10.1021/acschemneuro.5b00304. Epub 2016 Jan 19. PubMed PMID: 26754558. 3: Brooks RR, Miller KE, Jones SM, Burns RH, Huang CT. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions. J Pharm Sci. 1990 May;79(5):384-8. PubMed PMID: 2161922. 4: Almquist RG, Steeger T, Jackson S, Mitoma C. Absorption, metabolism, and excretion studies of carbon 14- and tritium-labeled derivatives of a ketomethylene containing tripeptide. Life Sci. 1985 Jul 29;37(4):299-305. PubMed PMID: 2989647. 5: Weare JA, Stewart TA, Gafford JT, Erdös EG. Inhibition of human converting enzyme in vitro by a novel tripeptide analog. Hypertension. 1981 May-Jun;3(3 Pt 2):I50-3. PubMed PMID: 6266959. 6: Grobelny D, Galardy RE. Inhibition of angiotensin converting enzyme by aldehyde and ketone substrate analogues. Biochemistry. 1986 Mar 11;25(5):1072-8. PubMed PMID: 3008817. 7: Stewart SE, Mangan MS, Bird PI, Kaiserman D. Detection of human and mouse granzyme B activity in cell extracts. Methods Mol Biol. 2012;844:251-60. doi: 10.1007/978-1-61779-527-5_18. PubMed PMID: 22262448. 8: Attwood MR, Francis RJ, Hassall CH, Kröhn A, Lawton G, Natoff IL, Nixon JS, Redshaw S, Thomas WA. New potent inhibitors of angiotensin converting enzyme. FEBS Lett. 1984 Jan 9;165(2):201-6. PubMed PMID: 6319181. 9: Madouri F, Chenuet P, Beuraud C, Fauconnier L, Marchiol T, Rouxel N, Ledru A, Gallerand M, Lombardi V, Mascarell L, Marquant Q, Apetoh L, Erard F, Le Bert M, Trovero F, Quesniaux VFJ, Ryffel B, Togbe D. Protein kinase Cθ controls type 2 innate lymphoid cell and T(H)2 responses to house dust mite allergen. J Allergy Clin Immunol. 2017 May;139(5):1650-1666. doi: 10.1016/j.jaci.2016.08.044. Epub 2016 Oct 14. PubMed PMID: 27746240. 10: Sedelies KA, Ciccone A, Clarke CJ, Oliaro J, Sutton VR, Scott FL, Silke J, Susanto O, Green DR, Johnstone RW, Bird PI, Trapani JA, Waterhouse NJ. Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity. Cell Death Differ. 2008 Apr;15(4):708-17. doi: 10.1038/sj.cdd.4402300. Epub 2008 Jan 18. PubMed PMID: 18202705. 11: Marrocco V, Fiore P, Benedetti A, Pisu S, Rizzuto E, Musarò A, Madaro L, Lozanoska-Ochser B, Bouché M. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy. EBioMedicine. 2017 Feb;16:150-161. doi: 10.1016/j.ebiom.2017.01.001. Epub 2017 Jan 7. PubMed PMID: 28089792; PubMed Central PMCID: PMC5474428. 12: YOUMANS AS, YOUMANS GP. The effect of tween 80 in vitro on the bacteriostatic activity of 20 compounds for Mycobacterium tuberculosis. J Bacteriol. 1948 Aug;56(2):245-52. PubMed PMID: 18876858. 13: Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdös EG. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension. 1998 Apr;31(4):912-7. PubMed PMID: 9535414. 14: BODMAN RI, MORTON HJ, WYLIE WD. A new synthetic curarising agent: clinical trial of compound 20 (laudolissin). Lancet. 1952 Sep 13;2(6733):517-8. PubMed PMID: 12981890. 15: BODMAN RI. Some observations on the assaying of muscle relaxant in conscious volunteers, with special reference to compounds 15 et 20 of the heterocyclic decamethylene bis quaternary ammonium series. Anesth Anal. 1952 Feb;9(1):5-13. PubMed PMID: 14952846. 16: Almquist RG, Chao WR, Jennings-White C. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. J Med Chem. 1985 Aug;28(8):1067-71. PubMed PMID: 2991518. 17: Almquist RG, Jennings-White C, Chao WR, Steeger T, Wheeler K, Rogers J, Mitoma C. Synthesis and biological activity of pentapeptide analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. J Med Chem. 1985 Aug;28(8):1062-6. PubMed PMID: 2991517. 18: Nchinda AT, Chibale K, Redelinghuys P, Sturrock ED. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4612-5. Epub 2006 Jun 19. PubMed PMID: 16784850. 19: Almquist RG, Chao WR, Ellis ME, Johnson HL. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme. J Med Chem. 1980 Dec;23(12):1392-8. PubMed PMID: 6256550. 20: Sharma RK, Douglas RG, Louw S, Chibale K, Sturrock ED. New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme. Biol Chem. 2012 May;393(6):485-93. doi: 10.1515/hsz-2012-0127. PubMed PMID: 22628311.